Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I am considering creating a exploratory committee

to determine what rights and avenues Shareholders of PTSC have to protect their equitable interests and the interests of PTSC as an entity; against anyone or any other entity which has done or is doing harm to PTSC through acts of omission or commission

It is to be hoped that the current Board of Directors and all other employees(past, present, and future)with either stock options and or shares are fully supportive of any move to determine if there has been any fraudulent trading of PTSC stock.

Obviously, selling stock in order to repurchase at a lower price is of itself not fraudulent, as many momentum players will testify.



Shareholder equity is being diluted at a rapid rate in exchange for unknown and unestablished values, year end tax loss selling is upon us, and PTSC has taken an aggressive acquisitions strategy (yet another purchase will come by year end) with little cash and unproven cashflow negative operations

Would you care to explain the"rapid rate" of dilution and how you arrive at this conclusion?

Might the mere statement, "year end tax loss selling is upon us" be considered harmful as it predicates a falling share price and consequently an opportunity for momentum players? In fact, might the overall tone of the message be considered harmful to both PTSC and the equitable interests of shareholders?





Be well

Share
New Message
Please login to post a reply